Australian study uncovers mechanisms involved in the progression of Alzheimer's disease

A major Australian study has provided new insights into the loss of structure in regions of the brain and its potential association with Alzheimer's Disease. The findings recently reported in Neurology suggest a build-up of deposits of the protein amyloid-beta in a region of the brain known as the temporal inferior cortex. The region is connected to the hippocampus, which is involved in memory.

Alzheimer's is characterised by two factors: a build-up of amyloid-beta plaques in the brain, and a loss of neurons.

CSIRO's Preventative Health Flagship Theme Leader, Dr Cassandra Szoeke, said the puzzle for researchers was that the parts of the brain that had shrunk (atrophied) due to neuron loss were not the same as those showing increased deposits of amyloid-beta. Using MRI scans to study Alzheimer's disease-affected brain tissue, the researchers found that shrinking (atrophy) of the hippocampus was associated with plaque deposits in the temporal inferior cortex.

The results indicate that the increased accumulation of amyloid in the temporal inferior cortex disrupts connections with the hippocampus, causing the neurons to die.

"By helping to better understand the mechanisms involved in the progression of the disease, the study may guide the development of new strategies for early diagnosis," Dr Szoeke said.

The study involved advanced techniques for analysing and comparing different types of brain scans. Lead researcher was Dr Perrick Bourgeat, from the Australian e-Health Research Centre - a joint venture between CSIRO and the Queensland Government.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Alzheimer's genetic risk studies undermined by systemic biases